Evidence map›Paper›PMID 38468286›Full record

ArticleGenome biology2024

Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes.

Adrià Aterido, María López-Lasanta, Francisco Blanco, Antonio Juan-Mas, María Luz García-Vivar, Alba Erra, Carolina Pérez-García, Simón Ángel Sánchez-Fernández, Raimon Sanmartí, Antonio Fernández-Nebro and 14 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Machine learning in AIRR diagnostics: Advances and applications.Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  4. Challenges and future directions of AIRR-seq-based diagnostics.Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 2 countries.

Adrià AteridoRheumatology Research Group, Vall Hebron Research Institute, 08035, Barcelona, Spain.
María López-LasantaRheumatology Research Group, Vall Hebron Research Institute, 08035, Barcelona, Spain.
Francisco BlancoRheumatology Department, Hospital Juan Canalejo, A Coruña, Spain.
Antonio Juan-MasRheumatology Department, Hospital Son Llatzer, Palma, Spain.
María Luz García-VivarRheumatology Department, Hospital Universitario Barsuto, Bilbao, Spain.
Alba ErraRheumatology Research Group, Vall Hebron Research Institute, 08035, Barcelona, Spain.
Carolina Pérez-GarcíaRheumatology Department, Parc de Salut Mar, Barcelona, Spain.
Simón Ángel Sánchez-FernándezRheumatology Department, Hospital La Mancha Centro, Alcázar de San Juan, Spain.
Raimon SanmartíRheumatology Department, Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain.
Antonio Fernández-NebroRheumatology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.
Mercedes Alperi-LópezRheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Jesús TorneroRheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Spain.
Ana María OrtizRheumatology Department, Hospital Universitario La Princesa, IIS La Princesa, Madrid, Spain.
Carlos Marras Fernández-CidRheumatology Department, Hospital Universitario Virgen de La Arrixaca, Murcia, Spain.
Núria PalauRheumatology Research Group, Vall Hebron Research Institute, 08035, Barcelona, Spain.
Wenjing PaniRepertoire Inc, Huntsville, AL, USA.
Miranda Byrne-SteeleiRepertoire Inc, Huntsville, AL, USA.
Dmytro StarenkiiRepertoire Inc, Huntsville, AL, USA.
Daniel WeberiRepertoire Inc, Huntsville, AL, USA.
Ivan Rodriguez-NunezHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Jian HaniRepertoire Inc, Huntsville, AL, USA.
Richard M MyersHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Sara MarsalRheumatology Research Group, Vall Hebron Research Institute, 08035, Barcelona, Spain.
Antonio JuliàRheumatology Research Group, Vall Hebron Research Institute, 08035, Barcelona, Spain. toni.julia@vhir.org.ORCID 0000-0001-6064-3620
Vall d'Hebron Institut de Recerca · ESiRepertoire (United States) · USHospital San Juan de la Cruz · ESHudsonAlpha Institute for Biotechnology · USHospital Clínic de Barcelona · ESHospital Regional Universitario de Málaga · ESHospital Son Llatzer · ESHospital Universitario Central de Asturias · ESHospital Universitario de Guadalajara · ESHospital Universitario de La Princesa · ESHospital Universitario Virgen de la Arrixaca · ESParc de Salut · ES

Funding

Instituto de Salud Carlos III PI17/00019Ministerio de Economía y Competitividad IPT010000-2010-36
6 · The paper itself

Abstract

backgroundIn rheumatoid arthritis (RA), the activation of T and B cell clones specific for self-antigens leads to the chronic inflammation of the synovium. Here, we perform an in-depth quantitative analysis of the seven chains that comprise the adaptive immune receptor repertoire (AIRR) in RA.

resultsIn comparison to controls, we show that RA patients have multiple and strong differences in the B cell receptor repertoire including reduced diversity as well as altered isotype, chain, and segment frequencies. We demonstrate that therapeutic tumor necrosis factor inhibition partially restores this alteration but find a profound difference in the underlying biochemical reactivities between responders and non-responders. Combining the AIRR with HLA typing, we identify the specific T cell receptor repertoire associated with disease risk variants. Integrating these features, we further develop a molecular classifier that shows the utility of the AIRR as a diagnostic tool.

conclusionsSimultaneous sequencing of the seven chains of the human AIRR reveals novel features associated with the disease and clinically relevant phenotypes, including response to therapy. These findings show the unique potential of AIRR to address precision medicine in immune-related diseases.

Indexed as

Arthritis, RheumatoidB-LymphocytesHumansPhenotypeSynovial MembraneTumor Necrosis Factor-alphaTumor Necrosis Factor-alpha

Identifiers

PMID38468286
PMCPMC10926600
OpenAlexW4392659356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.